⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Global Drug Discovery Market (2026-2031) - AI-Driven Target Identification Accelerates Growth
globenewswire.com
NVDA
LLY
CHAI
TMO
ABBV
AMGN
AZN
BDX
BMY
CRL
JNJ
MRK
NVS
PFE
REGN
SNY
VRTX
Drug Repurposing Market - Global Strategic Business Report: Forecasts Growth to $37.3Billion by 2030, Profiling AbbVie, AstraZeneca, Pfizer, Novartis & Johnson & Johnson
globenewswire.com
ABBV
AZN
PFE
NVS
JNJ
AMGN
BMY
GILD
BIIB
TXMD
UTHR
Head and Neck Squamous Cell Carcinoma (HNSCC) - Market Insights, Epidemiology, and Market Forecast - 2036 | Set to Reach $2.56 Billion as HPV-Targeted Vaccines Reshape Care
globenewswire.com
MRK
BMY
JNJ
PDS
BNTX
INO
IMPP
CUE
CAR T-Cell Therapy Market Forecasts Growth from $7.24B (2026) to $13.78B by 2031, Profiling Bristol-Myers Squibb, Gilead Sciences, Novartis & J&J
globenewswire.com
BMY
GILD
JNJ
BioFuture 2026 Convenes Industry Leaders in New York City to Explore the Trends Reshaping Biopharma and Healthcare
prnewswire.com
JNJ
REGN
TMO
Liz Fowler Joins Upside's Board of Directors
prnewswire.com
JNJ
Waltz Health and Fresenius Kabi Expand Direct Access to Biosimilars Through Waltz Connect Platform
prnewswire.com
FMS
ABBV
JNJ
Johnson & Johnson presents new data reinforcing sustained disease control and improved daily function achieved with IMAAVY® (nipocalimab-aahu) in generalized myasthenia gravis (gMG)
prnewswire.com
JNJ
Cyted Health appoints Thomas West as Board Chair and Robert Epstein as Non-Executive Director to drive US growth
prnewswire.com
BSX
MDT
HOLX
JNJ
VERX
ILMN
CytoHub Co-Founder Aitor Aguirre Named to Lead Cardiac Tissue Engineering at NIH's First National Organoid Center
businesswire.com
JNJ
SNY
LLY
NVDA